Vesteck, a medical device company in West Chester that is working on a cardiac catheter that repairs the aorta, has raised $4.3 million in a private stock sale, writes John George for the Philadelphia Business Journal.

The New World Angels of South Florida led Series A with a $1.1 million investment. Other investors included DeepWork Capital and Ocean Azul Partners, both based in Florida. Locally, Ben Franklin Technology Partners of Southeastern Pennsylvania, Robin Hood Ventures, and the Delaware Crossing Investor Group took part.

The company will use the funds to support product manufacturing and pre-clinical testing, as well as its first in-human studies of an innovative cardiac technology.

Vesteck CEO Joe Rafferty said the company plans to start human testing of its lead product, the “super-tight catheter.” This device delivers nitinol sutures more easily than existing endovascular or surgical options. The company plans testing for sometime next year.

Steve O’Hara, president of New World Angels, explained his interest. He was attracted by the Vesteck technology designed to “improve patient outcomes for a number of less invasive surgeries, starting with endovascular aortic repair procedures.”

Read more about Vesteck in the Philadelphia Business Journal.